![Martin Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Evans
Fondateur chez
Celixir Plc
Fortune : 2 M $ au 31/12/2025
Profil
Martin John Evans is the founder of Oncogeni Ltd. founded in 2019, holding the title of Director since 2022.
Dr. Evans was the founder of Cell Therapy Ltd. founded in 2009, holding the titles of President & Chief Scientific Officer from 2015 to 2018.
Dr. Evans is the founder of Cardiogeni Plc founded in 2016, holding the titles of Director & Chief Scientific Officer since 2016.
Former jobs include Non-Executive Director at Coiled Therapeutics Plc from 2024 to 2025 and President at the University of Cardiff.
Education history includes a doctorate from University College London conferred in 1969 and an undergraduate degree from Christ's College (United Kingdom) conferred in 1963.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 18,92 % | 21/04/2026 | 16 855 254 ( 18,92 % ) | 2 M $ | 31/12/2025 |
| 03/12/2024 | 269 ( 0 % ) | 35 $ | 31/07/2026 |
Postes actifs de Martin Evans
| Sociétés | Poste | Début |
|---|---|---|
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Fondateur | 28/12/2016 |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Fondateur | 01/05/2019 |
Anciens postes connus de Martin Evans
| Sociétés | Poste | Fin |
|---|---|---|
| ROQT THER | Directeur Technique/Scientifique/R&D | 23/05/2024 |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | President | - |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Fondateur | - |
Formation de Martin Evans
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Christ's College (United Kingdom)
 Christ's College (United Kingdom) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
